Cerca e trova il CMO / CDMO di cui hai bisogno
Discover highly skilled partners for your drug development and manufacturing project.
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
Una struttura API e produzione intermedia approvata dalla USFDA.
Location available after registration
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
Impianto Chimico-Farmaceutico
Location available after registration
These facilities match your main criteria but not all optional filters.
Avara Pharmaceutical Services | Arecibo Site
AVARA
Impianto di produzione di dosaggi solidi orali (OSD) su scala commerciale con una forte esperienza nelle sostanze controllate (DEA II V).
DIMENSIONE DEL LOTTO: Medio, Grande
AREE TERAPEUTICHE DI COMPETENZA (ATC): (R) Respiratory system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (N) Nervous system, (B) Blood and blood forming organs
CATEGORIA / PRODOTTO: FDF / DRUG PRODUCTS, SERVICES, PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC
COMPLIANCE: Roszdravnadzor (Russia GMP), EMA (GMP UE), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), FDA (cGMP), Health Canada (Canada GMP), MFDS/KFDA (Repubblica di Corea GMP), ICH
SOSTANZE CONTROLLATE: Lowest potential for abuse, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
MERCATI: ANVISA (Brazil), PMDA (Japan), FDA (USA), Russian Health Authorities, EMA (EU), MFDS (South Korea), TGA (Australia), Health Canada (Canada)
USO: Umano
SERVIZI: Analytical / QC services, Manufacturing services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
REGIONE: North America
Avara Pharmaceutical Services | Norman Site
AVARA
Impianto di produzione a contratto specializzato nel dosaggio solido orale (OSD) per la fornitura clinica e commerciale.
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
AREE TERAPEUTICHE DI COMPETENZA (ATC): (R) Respiratory system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (N) Nervous system, (B) Blood and blood forming organs
CATEGORIA / PRODOTTO: FDF / DRUG PRODUCTS, SERVICES, PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC
COMPLIANCE: Roszdravnadzor (Russia GMP), EMA (GMP UE), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MHRA (UK GMP), TGA (Australia GMP), FDA (cGMP), Health Canada (Canada GMP), MFDS/KFDA (Repubblica di Corea GMP), ICH
SOSTANZE CONTROLLATE: Lowest potential for abuse, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
MERCATI: ANVISA (Brazil), PMDA (Japan), FDA (USA), Russian Health Authorities, EMA (EU), MFDS (South Korea), TGA (Australia), Health Canada (Canada), MHRA (UK)
USO: Umano
SERVIZI: Analytical / QC services, Manufacturing services, Development services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
REGIONE: North America
CARBOGEN AMCIS | Manchester, UK
CARBOGEN AMCIS
Scopri le nostre capacità di produzione di ingredienti cosmetici, prodotti di chimica fine e capacità di sintesi personalizzata di intermedi farmaceutici.
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
CATEGORIA / PRODOTTO: SERVICES, PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC
REGIONE: Europe
SERVIZI: Analytical / QC services, Manufacturing services, Development services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
COMPLIANCE: ECOVADIS, ISO, Consiglio di ricerca halal
CARBOGEN AMCIS | Aarau
CARBOGEN AMCIS
Sviluppo e produzione cGMP su media scala inclusa la cromatografia.
DIMENSIONE DEL LOTTO: Piccolo, Medio
COMPLIANCE: PMDA/MHLW (Japan GMP), Organizzazione Mondiale della Sanità (GMP / HACCP), FDA (cGMP), ISO
CATEGORIA / PRODOTTO: SERVICES, PARTICLE ENGINEERING, BIOLOGIA, CHEMICAL-SYNTHETIC
REGIONE: Europe
MERCATI: ANVISA (Brazil), PMDA (Japan), FDA (USA), CDSCO (India), EMA (EU), MFDS (South Korea), TGA (Australia), NMPA (China), Health Canada (Canada), MHRA (UK)
USO: Umano, Veterinario
SERVIZI: Analytical / QC services, Manufacturing services, Development services, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
CARBOGEN AMCIS | Bubendorf
CARBOGEN AMCIS
Sviluppo e produzione cGMP di API altamente potenti, inclusi coniugati di farmaci anticorpali (ADC).
MERCATI: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
DIMENSIONE DEL LOTTO: Piccolo, Medio
AREE TERAPEUTICHE DI COMPETENZA (ATC): (R) Respiratory system, (V09-10) Radiopharmaceuticals, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (B) Blood and blood forming organs
COMPLIANCE: EMA (GMP UE), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Organizzazione Mondiale della Sanità (GMP / HACCP), FDA (cGMP), ISO
CATEGORIA / PRODOTTO: SERVICES, PARTICLE ENGINEERING, BIOLOGIA, CHEMICAL-SYNTHETIC
REGIONE: Europe
USO: Umano, Veterinario
SERVIZI: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/giorno), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
PHARMALOOP S.L. - a Salvat Company
Laboratorios Salvat
Soluzioni CDMO completamente integrate per Blow-Fill-Seal (BFS), multidose sterile, multidose non sterile, bustine, capsule e compresse.
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
CATEGORIA / PRODOTTO: FDF / DRUG PRODUCTS, PARTICLE ENGINEERING
COMPLIANCE: EMA (GMP UE), FDA (cGMP), ISO
REGIONE: Europe
USO: Umano
SERVIZI: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
MERCATI: FDA (USA), EMA (EU)
AREE TERAPEUTICHE DI COMPETENZA (ATC): (V01) Allergens, (S) Sensory organs
BSL (Livello di sicurezza biologica): 1
OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 10,000 µg/day)
PARTICLE ENGINEERING manufacturing site
MAI network supplier
Un produttore API e intermedio con certificazioni globali.
Location available after registration
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
Impianto per inalazione di polvere secca.
Location available after registration
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
Il tuo CDMO GMP di fiducia per la produzione avanzata di prodotti farmaceutici asettici e non asettici, lo sviluppo di formulazioni e test analitici.
Location available after registration